Risk factor
Good trading liquidity
Profitability factor
Very strong margins and returns
About
Xiamen Amoytop Biotech Co., Ltd. specializes in the creation, commercialization, and distribution of biopharmaceutical products within China, utilizing advanced genetic engineering techniques. Its offerings span a variety of pharmaceutical goods, including finished drug formulations, diagnostic reagents, and active pharmaceutical ingredients (APIs). The company further extends its services to include bespoke contract manufacturing. Founded in 1996, the firm is headquartered in Xiamen, China.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBI